glp-1 agonist indications receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits GLP-1 Agonists Market Report 2025-2033,

Fatigue and weakness may occur, particularly during the initial treatment period as the body adjusts to the metabolic effects of the medication

Research Use Limitation Used solely for in vitro experiments Not permitted for clinical trials involving humans Not permitted for human or veterinary administration Not permitted for investigational human use Independently analysed by Liquilabs s.r.o

Does the report cover Japan in its regional analysis

doi: 10.1007/s00005-020-00584-4 64 ColomboEBassaniCDe AngelisARuffiniFOttoboniLComiGet al

Request thyroid function tests: If you experience palpitations along with other symptoms like weight changes, temperature sensitivity, or fatigue, consult your doctor and ask for thyroid function tests

[Google Scholar] 216.US Congress